46. Malignant rheumatoid arthritis Clinical trials / Disease details

Clinical trials : 4,356 / Drugs : 2,567 - (DrugBank : 415) / Drug target genes : 192 - Drug target pathways : 228

5 trials found

diseases per page:

Showing 1 to 5 of 5 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05447520 (ClinicalTrials.gov)	July 15, 2022	1/7/2022	Montelukast Use in Rheumatoid Arthritis	Clinical Study Evaluating the Efficacy and Safety of Adjunctive Use of Montelukastin Rheumatoid Arth ...	Rheumatoid Arthritis	Drug: Montelukast;Drug: Placebo;Drug: Conventional DMARDs	Noha Mansour	NULL	Recruiting	18 Years	80 Years	All	50	Phase 2	Egypt
2	NCT03770923 (ClinicalTrials.gov)	October 1, 2018	7/12/2018	Effect of Some Drugs on Rheumatoid Arithritis Activity	Clinical Study Evaluating the Effect of Histamine 1 Receptor Antagonist and Leukotreine Receptor Ant ...	Rheumatoid Arthritis	Drug: Rupatadine;Drug: Montelukast	Sherief Abd-Elsalam	NULL	Recruiting	18 Years	N/A	All	75	Phase 3	Egypt
3	NCT03131973 (ClinicalTrials.gov)	May 13, 2017	25/4/2017	Effects of Concomitant Administration of BMS-986195 on Methotrexate, Caffeine, Montelukast, Flurbipr ...	Effects of Concomitant Administration of BMS-986195 on the Single-dose Pharmacokinetics of Methotrex ...	Rheumatoid Arthritis	Drug: BMS-986195;Drug: Methotrexate;Drug: Leucovorin;Drug: Caffeine;Drug: Montelukast;Drug: Flurbipr ...	Bristol-Myers Squibb	NULL	Completed	18 Years	50 Years	All	26	Phase 1	United States
4	NCT02762123 (ClinicalTrials.gov)	May 2016	3/5/2016	A Study to Assess the Effect of BMS-986142 on Pharmacokinetics (PK) of Probe Substrates	Effects of Concomitant Administration of BMS-986142 on the Single-dose Pharmacokinetics of Probe Sub ...	Rheumatoid Arthritis	Drug: BMS-986142 200mg;Drug: BMS Drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazol ...	Bristol-Myers Squibb	NULL	Completed	18 Years	50 Years	Both	28	Phase 1	United States
5	NCT02456844 (ClinicalTrials.gov)	May 2015	27/5/2015	Study to Investigate the Effect of BMS-986142 on the Pharmacokinetics (PK) of Methotrexate and Probe ...	Effects of BMS-986142 on the Single-dose Pharmacokinetics of Methotrexate and Probe Substrates Monte ...	Rheumatoid Arthritis	Drug: Montelukast , Flurbiprofen, Midazolam, Digoxin, Pravastatin and BMS-986142;Drug: Methotrexate , ...	Bristol-Myers Squibb	NULL	Completed	18 Years	50 Years	Both	24	Phase 1	NULL

First Previous1Next Last